Costa Rica vs Northern Europe: Proportion of the target population who received a 3rd dose of
Costa Rica
99.0%
in 2024
Northern Europe
89.0%
in 2024
Costa Rica rank
1st
Northern Europe rank
2nd
Proportion of the target population who received a 3rd dose of over time
- Costa Rica
- Northern Europe
How they compare
Costa Rica currently reports 99.0% against 89.0% in Northern Europe, a difference of 10.0%.
That makes Costa Rica's figure about 1.1 times Northern Europe's.
The two have swapped places 6 times across 16 shared years of data; in 2009 it was Costa Rica ahead.
Costa Rica ranks 1st and Northern Europe ranks 2nd of 157 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Northern Europe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.0% | 18.0% | 30.0% | Costa Rica |
| 2010s | 90.2% | 89.1% | 1.1% | Costa Rica |
| 2020s | 94.2% | 89.4% | 4.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Costa Rica or Northern Europe?
- Costa Rica, at 99.0% against 89.0% in Northern Europe as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Costa Rica and Northern Europe?
- 10.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Northern Europe?
- 16 years are reported by both, from 2009 to 2024.
- How do Costa Rica and Northern Europe rank globally for proportion of the target population who received a 3rd dose of?
- Costa Rica ranks 1st and Northern Europe ranks 2nd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.